---
title: "Major Investor Makes Bold Moves in Shuttle Pharmaceuticals Holdings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292004249.md"
description: "Shuttle Pharmaceuticals Holdings (SHPH) saw significant insider trading by HRT Financial LP, which bought and sold shares in July 2026. The company announced plans for a reverse stock split and a new cryptocurrency subsidiary focusing on data centers in Idaho and Alberta. Despite these strategic moves, SHPH faces severe financial challenges, including zero revenue, cash burn, and an -80.56% YTD price decline. TipRanks' AI analyst rates the stock as 'Underperform' due to bearish technicals and valuation concerns."
datetime: "2026-07-08T02:02:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292004249.md)
  - [en](https://longbridge.com/en/news/292004249.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292004249.md)
generator: "portal-rs"
---

# Major Investor Makes Bold Moves in Shuttle Pharmaceuticals Holdings

New insider activity at Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH) ) has taken place on July 7, 2026.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Significant shareholder HRT FINANCIAL LP has been actively trading Shuttle Pharmaceuticals Holdings, Inc. stock, recently buying 7,851 shares in a transaction valued at $27,792 while also selling 9,022 shares for proceeds of $31,667. These moves highlight ongoing portfolio adjustments in the company’s stock by a major institutional investor.

**Recent Updates on SHPH stock** 

Shuttle Pharmaceuticals Holdings, Inc. saw heightened activity as its United Dogecoin subsidiary detailed plans to build proprietary data center and power assets in Idaho and Alberta, aiming to exploit low-cost renewable energy and favorable regulation for mining and future AI workloads, which could diversify revenue.

At the same time, the company disclosed a planned reverse stock split under Form 8-K, signaling a capital-structure change likely aimed at meeting listing requirements and stabilizing trading, while trading was halted pending news, against a backdrop of no current revenue, cash burn, and bearish technical sentiment that weigh on valuation and outlook.

**Spark’s Take on SHPH Stock**

According to Spark, TipRanks’ AI Analyst, SHPH is a Underperform.

Shuttle Pharmaceuticals Holdings, Inc. faces significant financial challenges with no revenue and ongoing cash burn. Technical indicators show bearish trends, and valuation metrics highlight the company’s unprofitability. While recent corporate activities offer potential strategic benefits, they also add financial strain and governance complexities, leading to an overall low stock score.

To see Spark’s full report on SHPH stock,  
 click here. 

**More about Shuttle Pharmaceuticals Holdings, Inc.**

**YTD Price Performance:** -80.56%

**Average Trading Volume:** 863,782

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $2.28M

### Related Stocks

- [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md)

## Related News & Research

- [Microsoft employees reveal how much cash they're burning on AI](https://longbridge.com/en/news/296828490.md)
- [ETFs RDVY, BKLC, and LSGR Get Bullish Calls from AI for Growth Potential](https://longbridge.com/en/news/296821798.md)
- [ZenaTech closes acquisition of Idaho civil engineering, land surveying firm Galena-Benchmark](https://longbridge.com/en/news/296824995.md)
- [WSHP: First half 2026 results released, highlighting platform growth and ongoing user ownership initiatives](https://longbridge.com/en/news/296829514.md)
- [Freeman Gold starts water, air baseline studies at Lemhi Gold Project in Idaho](https://longbridge.com/en/news/297177164.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**